Sterne Kessler is proud to rank among the top 5 firms for overall diversity and among the top 3 firms for equity partnership diversity in our size category, as reported in Law360’s 2022 Diversity Snapshot. "We strive to continue increasing our diversity in all of our attorney and staff levels by fostering a welcoming, equitable, and inclusive culture, providing professional development and mentoring, and offering insightful programming," said Director and Diversity & Inclusion Committee Chair Gaby Longsworth.

Directors Richard M. Bemben, Michael D. Specht, and Daniel S. Block represented TrustID in a victory at the PTAB regarding the company's caller ID technology patent. Read more about the decision in the Law360 article "PTAB Won’t Ax Claims in Caller ID Patent Row on Remand."

Sterne Kessler secured a settlement on behalf of Catalyst Pharmaceuticals, Inc. regarding ongoing patent infringement litigation with Jacobus Pharmaceutical Company, Inc. and PANTHERx Rare LLC. Catalyst will dismiss all claims asserting infringement against Jacobus of Catalyst’s patents relating to its proprietary FIRDAPSE® product that treats Lambert-Eaton myasthenic syndrome (LEMS) treatment.